Unity Biotechnology, Inc.
UBXDelisted Aug 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001463361
Unity Biotechnology, Inc. was delisted on Aug 6, 2025; its insiders filed their last Form 4 on Apr 3, 2025; 35 institutions reported holding it in 13F filings for Q2 2025, worth $987.3K in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Unity Biotechnology, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- 0 vs. Q2 2024
- Shares held
- 3.46M
- +98.0K (+2.9%) vs. Q2 2024
- Total value
- $5.09M
- +$548.3K (+12.1%) vs. Q2 2024
- New holders
- 7
- 4 more added
- Sold out
- 7
- 9 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting UBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 6 | $1.68K |
| Q2 2025 | 35 | $987.3K |
| Q1 2025 | 40 | $2.95M |
| Q4 2024 | 37 | $3.10M |
| Q3 2024 | 38 | $5.09M |
| Q2 2024 | 39 | $4.66M |
| Q1 2024 | 40 | $5.87M |
| Q4 2023 | 42 | $8.33M |
| Q3 2023 | 36 | $6.42M |
| Q2 2023 | 40 | $6.87M |
| Q1 2023 | 46 | $5.13M |
| Q4 2022 | 54 | $12.6M |
| Q3 2022 | 72 | $24.1M |
| Q2 2022 | 66 | $5.31M |
| Q1 2022 | 71 | $14.2M |
| Q4 2021 | 72 | $21.3M |
| Q3 2021 | 84 | $42.1M |
| Q2 2021 | 98 | $84.0M |
| Q1 2021 | 92 | $121.8M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Unity Biotechnology, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 120 | $0 | 0.00% | −271−69.3% | Reduced |
| FMR LLC | 10 | $15 | 0.00% | +10 | New |
| HHM Wealth Advisors, LLC | 25 | $37 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 26 | $38 | 0.00% | +26 | New |
| Jaffetilchin Investment Partners, LLC | 50 | $74 | 0.00% | +50 | New |
| AllSquare Wealth Management LLC | 55 | $81 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 61 | $90 | 0.00% | −43,341−99.9% | Reduced |
| Ameritas Investment Partners, Inc. | 100 | $147 | 0.00% | 00.0% | Unchanged |
| Carmichael Hill & Associates, Inc. | 100 | $147 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 126 | $185 | 0.00% | +1+0.8% | Added |
| Signaturefd, LLC | 200 | $294 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 200 | $294 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 272 | $400 | 0.00% | −511−65.3% | Reduced |
| Whittier Trust Co | 360 | $529 | 0.00% | +360 | New |
| UBS Group AG | 387 | $569 | 0.00% | +387 | New |
| CWM, LLC | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Glen Eagle Advisors, LLC | 1,104 | $1.62K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 2,000 | $2.94K | 0.00% | −1,500−42.9% | Reduced |
| Tower Research Capital LLC (TRC) | 2,059 | $3.03K | 0.00% | −2,740−57.1% | Reduced |
| Advisor Group Holdings, Inc. | 11,463 | $16.8K | 0.00% | −1,600−12.2% | Reduced |
| Endowment Wealth Management, Inc. | 13,495 | $19.8K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 22,549 | $33.1K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 24,112 | $35.0K | 0.00% | −500−2.0% | Reduced |
| Bridgeway Capital Management, LLC | 25,000 | $36.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 37,824 | $55.6K | 0.00% | 00.0% | Unchanged |
| Cercano Management LLC | 41,238 | $60.6K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 44,691 | $65.7K | 0.00% | −8,517−16.0% | Reduced |
| Founders Fund V Management, LLC | 49,172 | $72.3K | 12.64% | 00.0% | Unchanged |
| Ballentine Partners, LLC | 57,046 | $83.9K | 0.00% | +57,046 | New |
| Citadel Advisors LLC | 69,210 | $101.7K | 0.00% | −2,998−4.2% | Reduced |
| UBS Oconnor LLC | 79,354 | $116.7K | 0.00% | +7,371+10.2% | Added |
| BlackRock, Inc. | 81,174 | $119.3K | 0.00% | +81,174 | New |
| Renaissance Technologies LLC | 93,670 | $137.7K | 0.00% | +29,088+45.0% | Added |
| Mayo Clinic | 124,081 | $182.4K | 6.29% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 163,242 | $240.0K | 0.00% | +14,199+9.5% | Added |
| Vanguard Group Inc | 590,770 | $868.4K | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 920,013 | $1.35M | 0.01% | 00.0% | Unchanged |
| ARCH Venture Management, LLC | 1,004,817 | $1.48M | 0.57% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,837−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,479−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,187−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −129−100.0% | Sold out |
| Redwood Wealth Management Group, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |